We are pleased to announce WuXi AppTec’s  listing of Initial Public Offering of common stock on the Shanghai Stock Exchange. Proceeds from the IPO will be used to build and expand our R&D facilities in China, further strengthening the company’s capabilities and capacities to better serve our global customers and partners.

It will also allow us to further focus on WuXi’s mission and to accelerate growth of our enabling platform. Our commitment has always remained the same – to empower and enable anyone and any company to advance medicines for patients faster.

Official Press Release